Septerna, Inc. Common Stock Earnings
The next earnings date for Septerna, Inc. Common Stock has not yet been scheduled.
Analyst Estimates of Septerna, Inc. Common Stock Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Septerna, Inc. Common Stock Earnings: Historical
| 08/10/2026 | After Market | $-0.29 | 39.58% |
| 05/11/2026 | After Market | $-0.19 | 56.82% |
| 03/26/2026 | --- | $-0.24 | 66.67% |
| 11/10/2025 | Before Market | $-0.10 | -112.66% |
| 08/11/2025 | After Market | $-0.56 | -160.22% |
| 05/15/2025 | After Market | $-0.49 | -28.95% |
| 03/27/2025 | --- | $-0.64 | 6.80% |
| 11/20/2024 | After Market | $-8.40 | -793.62% |
| 08/28/2024 | --- | $-12.76 | --- |
More About Septerna, Inc. Common Stock
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
“Septerna, Inc. Common Stock Earnings” Can Refer to the Septerna, Inc. Common Stock Earnings Date
Some people say “Septerna, Inc. Common Stock earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Septerna, Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Septerna, Inc. Common Stock Stock on the Earnings Date
If you own Septerna, Inc. Common Stock stock (SEPN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Septerna, Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Septerna, Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Septerna, Inc. Common Stock Earnings
You can contact us any time if you would like to ask questions about Septerna, Inc. Common Stock earnings or anything else related to the stock market.